Sonic Healthcare directors adjust equity holdings

Suzanne Crowe, a director at Sonic Healthcare Limited, engaged in an on-market purchase of 2,365 fully paid ordinary shares at $21.12 per share on 26 September 2025. This transaction increased her indirect holdings to 6,125 shares via Farnsworth Avenue Pty Ltd The Portsea Super Fund A/C, while her direct holdings remained at 3,788 shares.

Meanwhile, Christopher David Wilks, another director, saw several changes to his interests between 24 September 2025 and 29 September 2025. He forfeited 111,589 unlisted options ($32.79 exercise price) and 19,619 unlisted performance rights due to not meeting long-term incentive conditions. Concurrently, he acquired 18,107 unlisted performance rights with a nil exercise price, vesting on 2 March 2026. Additionally, 5,863 shares previously held indirectly via SHEST were legally transferred into his direct ownership.